Citigroup’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,474
Closed -$1K 6614
2022
Q2
$1K Sell
1,474
-107,605
-99% -$99K ﹤0.01% 6147
2022
Q1
$137K Buy
+109,079
New +$168K ﹤0.01% 4271
2021
Q3
Sell
-332
Closed -$1K 6458
2021
Q2
$1K Sell
332
-2,799
-89% -$5.19K ﹤0.01% 6073
2021
Q1
$7K Sell
3,131
-4,490
-59% -$11.8K ﹤0.01% 5825
2020
Q4
$19K Buy
7,621
+5,613
+280% +$12.4K ﹤0.01% 6702
2020
Q3
$5K Sell
2,008
-3,174
-61% -$9.24K ﹤0.01% 7061
2020
Q2
$18K Sell
5,182
-16,788
-76% -$53.1K ﹤0.01% 6716
2020
Q1
$51K Buy
+21,970
New +$61.7K ﹤0.01% 5968
2019
Q4
Sell
-3,652
Closed -$7K 7866
2019
Q3
$7K Sell
3,652
-1,226
-25% -$2.14K ﹤0.01% 7238
2019
Q2
$7K Sell
4,878
-3,400
-41% -$5.95K ﹤0.01% 7408
2019
Q1
$16K Sell
8,278
-3,774
-31% -$8.01K ﹤0.01% 7073
2018
Q4
$16K Buy
12,052
+3,185
+36% +$5.83K ﹤0.01% 6988
2018
Q3
$22K Buy
8,867
+1,121
+14% +$3.31K ﹤0.01% 7047
2018
Q2
$26K Buy
7,746
+2,811
+57% +$10.8K ﹤0.01% 6793
2018
Q1
$21K Buy
4,935
+820
+20% +$2.84K ﹤0.01% 6725
2017
Q4
$14K Buy
4,115
+4,011
+3,857% +$14.6K ﹤0.01% 6904
2017
Q3
$0 Sell
104
-85
-45% -$322 ﹤0.01% 7514
2017
Q2
$1K Buy
+189
New +$776 ﹤0.01% 7240
2016
Q1
Sell
-82
Closed 7863
2015
Q4
$0 Sell
82
-1,513
-95% -$5.08K ﹤0.01% 7949
2015
Q3
$5K Buy
+1,595
New +$3.71K ﹤0.01% 6763
2014
Q2
Sell
-212
Closed -$1K 7375
2014
Q1
$1K Buy
212
+179
+542% +$1.04K ﹤0.01% 6905
2013
Q4
$0 Buy
+33
New +$225 ﹤0.01% 7198

Other funds holding NYMX